CIK 1858198
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 80.84% | 29 |
| Unclassified | 18.82% | 2 |
| Health Care Providers & Services | 0.34% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | Unclassified | 17.32% | |
| 2 | PRAX | Praxis Precision Medicines, Inc. | Health Care | 10.32% |
| 3 | WHWK | Whitehawk Therapeutics, Inc. | Health Care | 5.58% |
| 4 | AXSM | Axsome Therapeutics, Inc. | Health Care | 4.57% |
| 5 | STRO | SUTRO BIOPHARMA, INC. | Health Care | 4.22% |
| 6 | PTGX | Protagonist Therapeutics, Inc | Health Care | 4.17% |
| 7 | ERAS | Erasca, Inc. | Health Care | 4.11% |
| 8 | TRVI | Trevi Therapeutics, Inc. | Health Care | 3.69% |
| 9 | TNGX | Tango Therapeutics, Inc. | Health Care | 3.60% |
| 10 | INSM | INSMED Inc | Health Care | 3.48% |
30/32 names classified · sector 81.2% of weight · industry 81.2% · mkt cap 79.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 81.2% of the book is sector-classified (unclassified names shown, never dropped).
Only 8% of book weight classified — the grid is NOT representative of the whole book.
Classified: 7.7% of book weight (2/31 names) · unclassified 92.3%: , PRAX, AXSM, STRO, PTGX, ERAS, TRVI, TNGX, INSM, EWTX +19 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | TERNS PHARMACEUTICALS INC | 440,000 | $23M | 17.3% | HOLD |
| 2 | PRAXPRAXIS PRECISION MEDICINES I | 42,900 | $14M | 10.3% | HOLD |
| 3 | WHWKWHITEHAWK THERAPEUTICS INC | 2,165,997 | $7M | 5.6% | HOLD |
| 4 | AXSMAXSOME THERAPEUTICS INC. | 36,200 | $6M | 4.6% | HOLD |
| 5 | STROSUTRO BIOPHARMA INC | 226,575 | $6M | 4.2% | NEW |
| 6 | PTGXPROTAGONIST THERAPEUTICS INC | 53,000 | $6M | 4.2% | HOLD |
| 7 | ERASERASCA INC | 340,000 | $6M | 4.1% | NEW |
| 8 | TRVITREVI THERAPEUTICS INC | 414,000 | $5M | 3.7% | HOLD |
| 9 | TNGXTANGO THERAPEUTICS INC | 230,264 | $5M | 3.6% | NEW |
| 10 | INSMINSMED INC | 28,497 | $5M | 3.5% | HOLD |
| 11 | EWTXEDGEWISE THERAPEUTICS INC | 133,000 | $4M | 3.1% | HOLD |
| 12 | RVMDREVOLUTION MEDICINES INC | 40,200 | $4M | 2.9% | ADD 46% |
| 13 | IRONDISC MEDICINE INC | 58,250 | $4M | 2.8% | HOLD |
| 14 | MBXMBX BIOSCIENCES INC | 121,524 | $4M | 2.7% | HOLD |
| 15 | SVRASAVARA INC | 605,280 | $3M | 2.5% | HOLD |
| 16 | UTHRUnited Therapeutics Corp. | 4,750 | $3M | 2.1% | HOLD |
| 17 | TVTXTRAVERE THERAPEUTICS INC | 91,000 | $3M | 2.0% | HOLD |
| 18 | IDYAIDEAYA BIOSCIENCES INC | 79,700 | $3M | 2.0% | NEW |
| 19 | CMPXCOMPASS THERAPEUTICS INC | 500,000 | $3M | 2.0% | NEW |
| 20 | OCULOCULAR THERAPEUTIX INC | 300,000 | $3M | 1.9% | NEW |
| 21 | VRDNVIRIDIAN THERAPEUTICS INC | 125,000 | $2M | 1.8% | NEW |
| 22 | DRUGBRIGHT MINDS BIOSCIENCES INC | 31,813 | $2M | 1.7% | NEW |
| 23 | ZURAZURA BIO LTD | 373,128 | $2M | 1.7% | NEW |
| 24 | SRRKSCHOLAR ROCK HLDG CORP | 45,000 | $2M | 1.7% | HOLD |
| 25 | IMMXIMMIX BIOPHARMA INC | 230,423 | $2M | 1.6% | HOLD |
| 26 | SOLENO THERAPEUTICS INC | 59,700 | $2M | 1.5% | HOLD |
| 27 | NKTRNEKTAR THERAPEUTICS | 26,900 | $2M | 1.4% | HOLD |
| 28 | CABACABALETTA BIO INC | 505,431 | $1M | 1.0% | HOLD |
| 29 | ACHVACHIEVE LIFE SCIENCES INC | 462,355 | $1M | 1.0% | HOLD |
| 30 | VERAVERA THERAPEUTICS INC | 32,700 | $1M | 1.0% | HOLD |
| 31 | CELCCELCUITY INC | 4,000 | $456,560 | 0.3% | HOLD |
| 32 | VYNEVYNE THERAPEUTICS INC | 500,551 | $299,079 | 0.2% | HOLD |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| TERNS PHARMACEUTICALS INC | — | — | — | — | 440K | 440K | $23M |
| PRAXPRAXIS PRECISION MEDICINES I | — | — | — | — | 43K | 43K | $14M |
| WHWKWHITEHAWK THERAPEUTICS INC | — | — | — | — | 2.2M | 2.2M | $7M |
| AXSMAXSOME THERAPEUTICS INC. | — | — | — | — | 36K | 36K | $6M |
| STROSUTRO BIOPHARMA INC | — | — | — | — | — | 227K | $6M |
| PTGXPROTAGONIST THERAPEUTICS INC | — | — | — | — | 53K | 53K | $6M |
| ERASERASCA INC | — | — | — | — | — | 340K | $6M |
| TRVITREVI THERAPEUTICS INC | — | — | — | — | 414K | 414K | $5M |
| TNGXTANGO THERAPEUTICS INC | — | — | — | — | — | 230K | $5M |
| INSMINSMED INC | — | — | — | — | 28K | 28K | $5M |
| EWTXEDGEWISE THERAPEUTICS INC | — | — | — | — | 133K | 133K | $4M |
| RVMDREVOLUTION MEDICINES INC | — | — | — | — | 28K | 40K | $4M |
| IRONDISC MEDICINE INC | — | — | — | — | 58K | 58K | $4M |
| MBXMBX BIOSCIENCES INC | — | — | — | — | 122K | 122K | $4M |
| SVRASAVARA INC | — | — | — | — | 605K | 605K | $3M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
